Mutations in SPOP that occur in cancer disrupt this regulatory mechanism, leading to the accumulation of NANOG and the promotion of cancer stem cell properties, ultimately contributing to prostate cancer progression [61, 62]. The gene discussed is NANOG; the disease is cancer.